Operating Lease, Right-of-Use Asset of Entrada Therapeutics, Inc. from 31 Dec 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Entrada Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2021 to 30 Sep 2025.
  • Entrada Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $62,122,000, a 16% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Entrada Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $62,122,000 -$11,651,000 -16% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $65,681,000 -$10,705,000 -14% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $68,423,000 -$10,535,000 -13% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $71,120,000 -$10,370,000 -13% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $73,773,000 -$10,244,000 -12% 30 Sep 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 $76,386,000 -$11,896,000 -13% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $78,958,000 +$64,711,000 +454% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $81,490,000 +$56,150,000 +222% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $84,017,000 +$56,635,000 +207% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $88,282,000 +$58,878,000 +200% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $14,247,000 -$17,162,000 -55% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $25,340,000 +$25,340,000 31 Dec 2022 10-K 13 Mar 2024 2023 FY
Q3 2022 $27,382,000 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $29,404,000 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $31,409,000 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $0 31 Dec 2021 10-Q 11 Aug 2022 2022 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.